CDMO & Contract Development • Integrated Concept to Commercialisation

Serving Customers Across the Pharma Value Chain

Chieron is a strategic partner for CDMO/CMO opportunities and API/Intermediates for clients across India, Europe, USA, Japan, South Korea, Brazil, China, and the Middle East.

We Retain Their Trust

Transparency, Predictability & Supply Security

With a strong foundation built on backward integration, green chemistry, and regulatory compliance, we aspire to achieve a top-three global market position for all our molecules. We emphasize transparency and proactive communication with clients to mitigate global raw material price fluctuations while ensuring uncompromised supply continuity.

8–10 Wks Max Lead Time
USFDA & EDQM Compliant
4–7 New APIs Annually
Top 3
Target Global Position

Aiming for leadership in all 15–20 commercial APIs through continuous synthesis.

Tailored Engagement Models

Dedicated Client Segment Teams

Specialized cross-functional experts with over two decades of industry experience across R&D, regulatory affairs, operations, and IT.

Led by R&D Head

Originators & Innovators

Cross-functional team handling early-stage inquiries, technical route design, non-infringing IP pathways, and rapid tech transfer to pilot scale.

Custom route scouting
Patent-fencing & FTO analysis
Kilo lab batches & impurity profiling
Dedicated Commercial & Tech Team

Specialty Chemicals

Manages complex chemical requirements and rigorous electronic/semiconductor grade specifications, ensuring seamless execution from lab to plant.

High pressure / cryo chemistry
Specialty fluorination & organometallics
High vacuum distillation
Sales & Supply Chain Team

Generic Pharma Leaders

Coordinates tight alignment between manufacturing, regulatory affairs, and inventory planning to deliver commercial APIs with an 8–10 week lead time.

Continuous manufacturing
Cost leadership via backward integration
USDMF / CEP / ASMF dossier filings
End-to-End Execution

Integrated from Concept to Commercialisation

A seamless, transparent pathway from laboratory synthesis to multi-ton commercial launch.

01

Route Scouting & R&D

Developing robust, non-infringing synthetic routes with high atom economy and green biocatalysis.

02

Analytical Method Validation

GLP/GDP compliant ADL methods, genotoxic impurity profiling, and nitrosamine risk assessments.

03

Kilo Lab & Pilot Scale

100L scale automated GLRs and pilot plant validation batches to establish process control parameters.

04

Regulatory Filing & Tech Transfer

Complete DMF preparation (US-DMF, CEP, Canada, Australia) and regulatory query resolution.

05

Commercial Manufacturing

350+ KL plant capacity, 7 ISO-8 cleanrooms, continuous manufacturing, and guaranteed 8–10 week lead time.

Have a New Chemical Entity (NCE) or Custom Synthesis Project?

Collaborate with our 20+ Ph.D. research scientists and experienced techno-legal patent team.

Discuss CDMO Collaboration